SCHEMBL6577810

SCHEMBL6577810

Cc1ccc(S(=O)(=O)c2ccc3c(c2)c(CCN)c(C)n3C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.41
HTR6 P50406 9/20 0.40
CA2 P00918 1/20 0.38
PIK3CG P48736 1/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 1/20 0.37
SPR P35270 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6580196 0.99 GAA (0.40) GAAHTR6CA2PIK3CGMEN1
SCHEMBL6575479 0.91 HTR6 (0.48) HTR6ALDH1A1MAPTHDAC3HDAC4
Hydrochloric Acid SCHEMBL6577375 0.90 HTR6 (0.48) HTR6ALDH1A1MAPTHDAC3HDAC4
SCHEMBL6577904 0.87 HTR6 (0.47) HTR6PIK3CGALDH1A1SPRPTGDR2
SCHEMBL6575514 0.86 HTR6 (0.45) HTR6PIK3CGSPRPTGDR2HDAC3
Hydrochloric Acid SCHEMBL6577960 0.86 HTR6 (0.46) HTR6ALDH1A1SPRPTGDR2HDAC3
Hydrochloric Acid SCHEMBL6577886 0.85 HTR6 (0.44) HTR6PIK3CGSPRPTGDR2HDAC3
SCHEMBL7163525 0.85 SPR (0.42) GAAHTR6CA2MEN1ALDH1A1
Hydrochloric Acid SCHEMBL6577151 0.84 SPR (0.42) GAAHTR6CA2MEN1ALDH1A1
SCHEMBL6575542 0.83 HTR6 (0.48) HTR6ALDH1A1PTGDR2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6565829-B2 Psychological disorders; central nervous system disorders PHARMACIA & UPJOHN COMPANY 2003-05-20 US claimed
US-20030060498-A1 5-arylsulfonyl indoles useful for treating disease PHARMACIA & UPJOHN COMPANY 2003-03-27 US claimed
EP-1411925-A1 5-ARYLSULFONYL INDOLES HAVING 5-HT6 RECEPTOR AFFINITY PHARMACIA & UPJOHN COMPANY (US) 2004-04-28 EP disclosed
US-6565829-B2 Psychological disorders; central nervous system disorders PHARMACIA & UPJOHN COMPANY 2003-05-20 US disclosed
US-20030060498-A1 5-arylsulfonyl indoles useful for treating disease PHARMACIA & UPJOHN COMPANY 2003-03-27 US disclosed
WO-2003011284-A1 5-ARYLSULFONYL INDOLES HAVING 5-HT6 RECEPTOR AFFINITY PHARMACIA & UPJOHN COMPANY (US) 2003-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060498-A1 5-arylsulfonyl indoles useful for treating disease IDO1, HTR5A, IDO2 GAA 1300/4885HTR6 14/4885CA2 4065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.